The expression and function of histamine H3 receptors in pancreatic beta cells

British Journal of Pharmacology

Volumn 171, Issue 1, 2014, Pages 171-185

  Nakamura, T ^a   Yoshikawa, T ^a   Noguchi, N ^a   Sugawara, A ^a   Kasajima, A ^a   Sasano, H ^a   Yanai, K ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

histamine H3 receptor; insulin secretion; pancreatic beta cells

Indexed keywords

ADENOSINE TRIPHOSPHATE; BROXURIDINE; CALCIUM; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUCOSE; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR AGONIST; IMETIT; INSULIN; POTASSIUM CHLORIDE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

HISTAMINE H3 RECEPTOR; INSULIN SECRETION; PANCREATIC BETA CELLS;

ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIUM SIGNALING; CELL LINE; CELL PROLIFERATION; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INVERSE AGONISM; GLUCOSE; HISTAMINE AGONISTS; HISTAMINE ANTAGONISTS; HISTIDINE DECARBOXYLASE; INSULIN; INSULIN-SECRETING CELLS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, KNOCKOUT; PHOSPHORYLATION; RECEPTORS, HISTAMINE H3; TIME FACTORS;

EID: 84890294472     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12429     Document Type: Article

References (66)

1. Ahren B, (2009). Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat Rev Drug Discov 8: 369-385.
2. Alexander SPH, et al. (2013). The Concise Guide to PHARMACOLOGY 2013/14: Overview. Br J Pharmacol 170: 1449-1867.
3. Arrang JM, Garbarg M, Schwartz JC, (1983). Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302: 832-837.
4. Barak N, Greenway FL, Fujioka K, Aronne LJ, Kushner RF, (2008). Effect of histaminergic manipulation on weight in obese adults: a randomized placebo controlled trial. Int J Obes (Lond) 32: 1559-1565.
5. Barbier AJ, Berridge C, Dugovic C, Laposky AD, Wilson SJ, Boggs J, et al. (2004). Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist. Br J Pharmacol 143: 649-661.
6. Bonaventure P, Letavic M, Dugovic C, Wilson S, Aluisio L, Pudiak C, et al. (2007). Histamine H3 receptor antagonists: from target identification to drug leads. Biochem Pharmacol 73: 1084-1096.
7. Bongers G, Sallmen T, Passani MB, Mariottini C, Wendelin D, Lozada A, et al. (2007). The Akt/GSK-3beta axis as a new signaling pathway of the histamine H(3) receptor. J Neurochem 103: 248-258.
8. Boyer DF, Fujitani Y, Gannon M, Powers AC, Stein RW, Wright CV, (2006). Complementation rescue of Pdx1 null phenotype demonstrates distinct roles of proximal and distal cis-regulatory sequences in pancreatic and duodenal expression. Dev Biol 298: 616-631.
9. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC, (2003). Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52: 102-110.
10. Chiba S, Itateyama E, Sakata T, Yoshimatsu H, (2009). Acute central administration of immepip, a histamine H3 receptor agonist, suppresses hypothalamic histamine release and elicits feeding behavior in rats. Brain Res Bull 79: 37-40.
11. Clark EA, Hill SJ, (1996). Sensitivity of histamine H3 receptor agonist-stimulated [35S]GTP gamma[S] binding to pertussis toxin. Eur J Pharmacol 296: 223-225.
12. Clark MA, Korte A, Egan RW, (1993). Guanine nucleotides and pertussis toxin reduce the affinity of histamine H3 receptors on AtT-20 cells. Agents Actions 40: 129-134.
13. Clineschmidt BV, Lotti VJ, (1973). Histamine: intraventricular injection suppresses ingestive behavior of the cat. Arch Int Pharmacodyn Ther 206: 288-298.
14. Cnop M, Hughes SJ, Igoillo-Esteve M, Hoppa MB, Sayyed F, Laar L, et al. (2009). The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. Diabetologia 53: 321-330.
15. Davenas E, Rouleau A, Morisset S, Arrang JM, (2008). Autoregulation of McA-RH7777 hepatoma cell proliferation by histamine H3 receptors. J Pharmacol Exp Ther 326: 406-413.
16. Devedjian JC, Pujol A, Cayla C, George M, Casellas A, Paris H, et al. (2000). Transgenic mice overexpressing alpha2A-adrenoceptors in pancreatic beta-cells show altered regulation of glucose homeostasis. Diabetologia 43: 899-906.
17. Drucker DJ, (2006). The biology of incretin hormones. Cell Metab 3: 153-165.
18. Drutel G, Peitsaro N, Karlstedt K, Wieland K, Smit MJ, Timmerman H, et al. (2001). Identification of rat H3 receptor isoforms with different brain expression and signaling properties. Mol Pharmacol 59: 1-8.
19. Dy M, Lebel B, Schneider E, (1982). Presence of histaminase in fetal calf sera. J Immunol Methods 48: 261-265.
20. 3H-histamine by the neuronal isoform of the vesicular monoamine transporter. J Mol Neurosci 6: 277-287.
21. Francis H, Franchitto A, Ueno Y, Glaser S, DeMorrow S, Venter J, et al. (2007). H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway. Lab Invest 87: 473-487.
22. Fukui H, Fujimoto K, Mizuguchi H, Sakamoto K, Horio Y, Takai S, et al. (1994). Molecular cloning of the human histamine H1 receptor gene. Biochem Biophys Res Commun 201: 894-901.
23. Gantz I, Munzert G, Tashiro T, Schaffer M, Wang L, DelValle J, et al. (1991). Molecular cloning of the human histamine H2 receptor. Biochem Biophys Res Commun 178: 1386-1392.
24. Garbarg M, Arrang JM, Rouleau A, Ligneau X, Tuong MD, Schwartz JC, et al. (1992). S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist. J Pharmacol Exp Ther 263: 304-310.
25. Gautam D, Han SJ, Hamdan FF, Jeon J, Li B, Li JH, et al. (2006). A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Cell Metab 3: 449-461.
26. UK Prospective Diabetes Study Group (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352: 837-853.
27. Haas HL, Sergeeva OA, Selbach O, (2008). Histamine in the nervous system. Physiol Rev 88: 1183-1241.
28. Halford JC, Boyland EJ, Blundell JE, Kirkham TC, Harrold JA, (2010). Pharmacological management of appetite expression in obesity. Nat Rev Endocrinol 6: 255-269.
29. Henry MB, Zheng S, Duan C, Patel B, Vassileva G, Sondey C, et al. (2011). Antidiabetic properties of the histamine H3 receptor protean agonist proxyfan. Endocrinology 152: 828-835.
30. Heron A, Rouleau A, Cochois V, Pillot C, Schwartz JC, Arrang JM, (2001). Expression analysis of the histamine H(3) receptor in developing rat tissues. Mech Dev 105: 167-173.
31. Hussain MA, Porras DL, Rowe MH, West JR, Song WJ, Schreiber WE, et al. (2006). Increased pancreatic beta-cell proliferation mediated by CREB binding protein gene activation. Mol Cell Biol 26: 7747-7759.
32. Jansson D, Ng AC, Fu A, Depatie C, Al Azzabi M, Screaton RA, (2008). Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2. Proc Natl Acad Sci U S A 105: 10161-10166.
33. Jhala US, Canettieri G, Screaton RA, Kulkarni RN, Krajewski S, Reed J, et al. (2003). cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev 17: 1575-1580.
34. 3 antagonists and donepezil on learning and mnemonic deficits induced by pentylenetetrazol kindling in weanling mice. Neuropharmacology 50: 404-411.
35. Jorgensen EA, Knigge U, Warberg J, Kjaer A, (2007). Histamine and the regulation of body weight. Neuroendocrinology 86: 210-214.
36. Kidd M, Tang LH, Miu K, Lawton GP, Sandor A, Modlin IM, (1996). Autoregulation of enterochromaffin-like cell histamine secretion via the histamine 3 receptor subtype. Yale J Biol Med 69: 9-19.
37. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
38. Knigge U, Soe-Jensen P, Jorgensen H, Kjaer A, Moller M, Warberg J, (1999). Stress-induced release of anterior pituitary hormones: effect of H3 receptor-mediated inhibition of histaminergic activity or posterior hypothalamic lesion. Neuroendocrinology 69: 44-53.
39. Leibiger IB, Leibiger B, Berggren PO, (2008). Insulin signaling in the pancreatic beta-cell. Annu Rev Nutr 28: 233-251.
40. Leurs R, Bakker RA, Timmerman H, de Esch IJ, (2005). The histamine H3 receptor: from gene cloning to H3 receptor drugs. Nat Rev Drug Discov 4: 107-120.
41. Lin CC, Anseth KS, (2011). Cell-cell communication mimicry with poly(ethylene glycol) hydrogels for enhancing beta-cell function. Proc Natl Acad Sci U S A 108: 6380-6385.
42. 4) expressed in bone marrow. Mol Pharmacol 59: 420-426.
43. Lovenberg TW, Roland BL, Wilson SJ, Jiang X, Pyati J, Huvar A, et al. (1999). Cloning and functional expression of the human histamine H3 receptor. Mol Pharmacol 55: 1101-1107.
44. 3 receptor reveals distinct species pharmacological profiles. J Pharmacol Exp Ther 293: 771-778.
45. Maintz L, Novak N, (2007). Histamine and histamine intolerance. Am J Clin Nutr 85: 1185-1196.
46. McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
47. Malmlof K, Zaragoza F, Golozoubova V, Refsgaard HH, Cremers T, Raun K, et al. (2005). Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight. Int J Obes (Lond) 29: 1402-1412.
48. Miyazaki J, Araki K, Yamato E, Ikegami H, Asano T, Shibasaki Y, et al. (1990). Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127: 126-132.
49. Morisset S, Rouleau A, Ligneau X, Gbahou F, Tardivel-Lacombe J, Stark H, et al. (2000). High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature 408: 860-864.
50. 2+ oscillations in the pancreatic beta-cell line, MIN6. Diabetologia 41: 279-286.
51. Ohtsu H, (2010). Histamine synthesis and lessons learned from histidine decarboxylase deficient mice. Adv Exp Med Biol 709: 21-31.
52. Ohtsu H, Watanabe T, (2003). New functions of histamine found in histidine decarboxylase gene knockout mice. Biochem Biophys Res Commun 305: 443-447.
53. Okamoto H, Noto Y, Miyamoto S, Mabuchi H, Takeda R, (1975). Inhibition by somatostatin of insulin release from isolated pancreatic islets. FEBS Lett 54: 103-105.
54. Okuda T, Zhang D, Shao H, Okamura N, Takino N, Iwamura T, et al. (2009). Methamphetamine- and 3,4-methylenedioxymethamphetamine-induced behavioral changes in histamine H3-receptor knockout mice. J Pharmacol Sci 111: 167-174.
55. Renstrom E, Ding WG, Bokvist K, Rorsman P, (1996). Neurotransmitter- induced inhibition of exocytosis in insulin-secreting beta cells by activation of calcineurin. Neuron 17: 513-522.
56. Rosengren AH, Jokubka R, Tojjar D, Granhall C, Hansson O, Li DQ, et al. (2010). Overexpression of alpha2A-adrenergic receptors contributes to type 2 diabetes. Science 327: 217-220.
57. Saisho Y, Harris PE, Butler AE, Galasso R, Gurlo T, Rizza RA, et al. (2008). Relationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreas. J Mol Histol 39: 543-551.
58. Saltiel AR, Kahn CR, (2001). Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414: 799-806.
59. 3 receptor. PLoS ONE 7: e42185.
60. Soleimanpour SA, Crutchlow MF, Ferrari AM, Raum JC, Groff DN, Rankin MM, et al. (2010). Calcineurin signaling regulates human islet β-cell survival. J Biol Chem 285: 40050-40059.
61. Sun P, Jin X, Koyama T, Li S, Kitamura Y, Kawasaki H, (2010). R-(-)-alpha-methylhistamine, a histamine H3 receptor agonist, induces endothelium-dependent vasodilation in rat mesenteric resistance arteries. Biol Pharm Bull 33: 58-63.
62. Torrent A, Moreno-Delgado D, Gomez-Ramirez J, Rodriguez-Agudo D, Rodriguez-Caso C, Sanchez-Jimenez F, et al. (2005). H3 autoreceptors modulate histamine synthesis through calcium/calmodulin- and cAMP-dependent protein kinase pathways. Mol Pharmacol 67: 195-203.
63. Uchizono Y, Iwase M, Nakamura U, Sasaki N, Goto D, Iida M, (2004). Tacrolimus impairment of insulin secretion in isolated rat islets occurs at multiple distal sites in stimulus-secretion coupling. Endocrinology 145: 2264-2272.
64. Wilson S, Chambers JK, Park JE, Ladurner A, Cronk DW, Chapman CG, et al. (1996). Agonist potency at the cloned human beta-3 adrenoceptor depends on receptor expression level and nature of assay. J Pharmacol Exp Ther 279: 214-221.
65. Yamamoto H, Matsumoto K, Araki E, Miyamoto E, (2003). New aspects of neurotransmitter release and exocytosis: involvement of Ca2+/calmodulin- dependent phosphorylation of synapsin I in insulin exocytosis. J Pharmacol Sci 93: 30-34.
66. Yamatodani A, Fukuda H, Wada H, Iwaeda T, Watanabe T, (1985). High-performance liquid chromatographic determination of plasma and brain histamine without previous purification of biological samples: cation-exchange chromatography coupled with post-column derivatization fluorometry. J Chromatogr 344: 115-123.